Alzamend Neuro, Inc. (ALZN) Balance Sheet
ALZN balance sheet, FY2026
April 30, 2026 · U.S. dollars$2.1M assets = $1.3M liabilities + $733,211 equity
Both columns are drawn to the same scale: what ALZN owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ALZN financial health
Descriptive bands, not a rating. Fiscal FY2026.
ALZN balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $132,293FY2017 | $2.1MFY2026 | +35.8%/yr | |
| Total liabilities | $717,223FY2017 | $1.3MFY2026 | +7.2%/yr | |
| Shareholders’ equity | −$584,930FY2017 | $733,211FY2026 | — | |
| Cash & short-term investments | $4,976FY2017 | $710,689FY2026 | +73.5%/yr | |
| Total debt | $591,258FY2017 | $300,714FY2024 | −9.2%/yr | |
| Net cash (debt) | −$586,282FY2017 | $75,334FY2024 | +$661,616 | |
| Working capital | −$659,930FY2017 | $418,345FY2026 | +$1.1M | |
| Current ratio | 0.08FY2017 | 1.31FY2026 | +1.23 | |
| Debt / equity | 0.00FY2019 | 0.17FY2021 | +0.17 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ALZN assets
ALZN liabilities and equity
ALZN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ALZN balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $710,689 | $3.9M | $376,048 | $5.1M | $14.1M | $1.9M | $90,285 | $42,606 | $545,000 | $4,976 |
| Cash & equivalents | $710,689 | $3.9M | $376,048 | $5.1M | $14.1M | $1.9M | $90,285 | $42,606 | $545,000 | $4,976 |
| Receivables | $0 | $0 | $0 | $0 | $0 | $16,210 | $194,278 | $285,354 | $424,351 | $1,700 |
| Inventory | $0 | $0 | $0 | $0 | $0 | −$16,210 | $0 | $0 | $0 | $0 |
| Other current assets | $1.1M | $228,719 | $79,194 | $694,923 | $349,723 | $983,320 | $1.5M | $1.2M | $1.4M | $50,617 |
| Total current assets | $1.8M | $4.2M | $455,242 | $5.8M | $14.4M | $2.9M | $1.8M | $1.5M | $2.4M | $57,293 |
| Property, plant & equipment (net) | $314,866 | $425,606 | $176,346 | $79,843 | $102,909 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $75,000 |
| Total assets | $2.1M | $4.6M | $631,588 | $5.9M | $14.5M | $2.9M | $1.8M | $1.5M | $2.4M | $132,293 |
| Liabilities | ||||||||||
| Accounts payable | $1.3M | $634,761 | $2.9M | $2.9M | $1.2M | $503,591 | $929,639 | $1.1M | $90,088 | $125,965 |
| Short-term debt | — | — | $300,714 | — | — | $335,303 | $63 | $79 | — | $591,258 |
| Deferred revenue | — | — | −$3.2M | — | — | — | −$63 | −$79 | — | $0 |
| Total current liabilities | $1.3M | $634,761 | $3.2M | $2.9M | $1.2M | $899,643 | $992,306 | $1.2M | $96,724 | $717,223 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $1.2M | $838,894 | $929,639 | $1.1M | $0 | $0 |
| Total liabilities | $1.3M | $634,761 | $3.2M | $2.9M | $1.2M | $899,643 | $992,306 | $1.2M | $96,724 | $717,223 |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $425 | $78 | $69 | $9,694 | $9,548 | $6,743 | $6,476 | $6,188 | $4,949 | $3,287 |
| Retained earnings (deficit) | −$67.3M | −$58.5M | −$54.0M | −$44.1M | −$29.2M | −$16.8M | −$11.8M | −$7.4M | −$2.5M | −$1.6M |
| Accumulated other comprehensive income | — | — | $0 | −$14.9M | −$14.9M | −$14.9M | −$15.0M | −$15.0M | −$4,949 | — |
| Total shareholders' equity | $733,211 | $4.0M | −$2.6M | $3.0M | $13.4M | $2.0M | $821,709 | $316,915 | $2.3M | −$584,930 |
| Key figures | ||||||||||
| Total debt | — | — | $300,714 | — | — | $335,303 | $63 | $79 | — | $591,258 |
| Net cash (debt) | — | — | $75,334 | — | — | $1.6M | $90,222 | $42,527 | — | −$586,282 |
| Working capital | $418,345 | $3.5M | −$2.8M | $3.0M | $13.2M | $2.0M | $821,709 | $316,915 | $2.3M | −$659,930 |
| Tangible book value | $733,211 | $4.0M | −$2.6M | $3.0M | $13.4M | $2.0M | $821,709 | $316,915 | $2.3M | −$584,930 |
| Book value per share | $0.22 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 3.3M | — | — | — | — | — | — | — | — | — |
| Current ratio | 1.31 | 6.58 | 0.14 | 2.03 | 12.37 | 3.24 | 1.83 | 1.27 | 24.98 | 0.08 |
| Quick ratio | 0.53 | 6.22 | 0.12 | 1.79 | 12.07 | 2.16 | 0.29 | 0.28 | 10.02 | 0.01 |
| Debt / equity | — | — | — | — | — | 0.17 | 0.00 | 0.00 | — | — |
| Equity / assets | 35.3% | 86.2% | −410.7% | 51.5% | 92.0% | 69.1% | 45.3% | 21.1% | 96.0% | −442.1% |
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | Oct '24 | Jul '24 | Apr '24 | Jan '24 | Oct '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $7.6M | $710,689 | $2.7M | $4.4M | $5.6M | $3.9M | $3.4M | $4.1M | $1.2M | $376,048 | $282,867 | $200,079 |
| Cash & equivalents | $7.6M | $710,689 | $2.7M | $4.4M | $5.6M | $3.9M | $3.4M | $4.1M | $1.2M | $376,048 | $282,867 | $200,079 |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $663,436 | $1.1M | $986,143 | $272,015 | $307,958 | $228,719 | $589,208 | $673,669 | $222,241 | $79,194 | $310,738 | $581,802 |
| Total current assets | $8.3M | $1.8M | $3.7M | $4.7M | $5.9M | $4.2M | $3.9M | $4.8M | $1.4M | $455,242 | $593,605 | $781,881 |
| Property, plant & equipment (net) | $287,181 | $314,866 | $342,551 | $370,236 | $397,921 | $425,606 | $228,291 | $240,976 | $253,661 | $176,346 | $189,031 | $201,716 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $70,000 | $0 |
| Total assets | $8.5M | $2.1M | $4.0M | $5.1M | $6.3M | $4.6M | $4.2M | $5.0M | $1.7M | $631,588 | $852,636 | $983,597 |
| Liabilities | ||||||||||||
| Accounts payable | $2.7M | $1.3M | $1.9M | $717,488 | $983,311 | $634,761 | $725,851 | $1.3M | $2.9M | $2.9M | $3.8M | $3.7M |
| Short-term debt | — | — | — | — | — | — | — | — | — | $300,714 | — | — |
| Deferred revenue | — | — | — | — | — | — | — | — | — | −$2.9M | — | — |
| Total current liabilities | $2.7M | $1.3M | $1.9M | $717,488 | $983,311 | $634,761 | $725,851 | $1.3M | $2.9M | $3.2M | $3.8M | $3.7M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.2M | $0 |
| Total liabilities | $2.7M | $1.3M | $1.9M | $717,488 | $983,311 | $634,761 | $725,851 | $1.3M | $2.9M | $3.2M | $5.0M | $3.7M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $482 | $425 | $380 | $380 | $314 | $78 | $580 | $523 | $86 | $69 | $662 | $647 |
| Retained earnings (deficit) | −$70.3M | −$67.3M | −$64.4M | −$62.2M | −$61.2M | −$58.5M | −$57.4M | −$56.4M | −$55.0M | −$54.0M | −$53.2M | −$50.5M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | — | $0 | −$477,737 | −$14.9M |
| Total shareholders' equity | $5.8M | $733,211 | $2.2M | $4.4M | $5.3M | $4.0M | $3.4M | $3.8M | −$1.2M | −$2.6M | −$4.2M | −$2.7M |
| Key figures | ||||||||||||
| Total debt | — | — | — | — | — | — | — | — | — | $300,714 | $477,737 | — |
| Net cash (debt) | — | — | — | — | — | — | — | — | — | $75,334 | −$194,870 | — |
| Working capital | $5.5M | $418,345 | $1.8M | $4.0M | $4.9M | $3.5M | $3.2M | $3.5M | −$1.5M | −$2.8M | −$3.2M | −$2.9M |
| Tangible book value | $5.8M | $733,211 | $2.2M | $4.4M | $5.3M | $4.0M | $3.4M | $3.8M | −$1.2M | −$2.6M | −$4.2M | −$2.7M |
| Book value per share | $1.30 | $0.22 | $0.57 | $1.29 | $2.54 | — | — | — | — | — | — | — |
| Shares outstanding | 4.5M | 3.3M | 3.8M | 3.4M | 2.1M | — | — | — | — | — | — | — |
| Current ratio | 3.01 | 1.31 | 1.99 | 6.58 | 6.03 | 6.58 | 5.44 | 3.80 | 0.49 | 0.14 | 0.16 | 0.21 |
| Quick ratio | 2.77 | 0.53 | 1.46 | 6.20 | 5.72 | 6.22 | 4.63 | 3.26 | 0.41 | 0.12 | 0.07 | 0.05 |
| Equity / assets | 67.9% | 35.3% | 54.0% | 85.9% | 84.5% | 86.2% | 82.6% | 74.9% | −72.6% | −410.7% | −491.9% | −272.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed July 22, 2026); data from EODHD.
ALZN financial position
At the end of fiscal 2026 (April 30, 2026), Alzamend Neuro had total assets of $2.1 million (down 54.8% from a year earlier), total liabilities of $1.3 million and shareholders' equity of $0.7 million. Its current ratio was 1.31. In the latest quarter (ended July 31, 2026) total assets were $8.5 million and equity $5.8 million.
Related: ALZN income statement, ALZN cash flow statement, ALZN key metrics. See the ALZN stock overview for the latest quote and news.
ALZN balance sheet FAQ
What are Alzamend Neuro's total assets?
Alzamend Neuro reported total assets of $2.1 million at the end of fiscal 2026 (April 30, 2026), compared with $4.6 million a year earlier.
How much cash does Alzamend Neuro have?
Alzamend Neuro held $0.7 million in cash and short-term investments at the end of fiscal 2026.
What is Alzamend Neuro's book value?
Alzamend Neuro's shareholders' equity (book value) was $0.7 million at the end of fiscal 2026, or $0.22 per share.
What is Alzamend Neuro's current ratio?
Alzamend Neuro had current assets of $1.8 million and current liabilities of $1.3 million, a current ratio of 1.31 (it can cover its short-term obligations).